1. A population‐based study of chronic myeloid leukemia patients treated with imatinib in first line. Issue 1 (18th November 2016) Authors: Castagnetti, Fausto; Di Raimondo, Francesco; De Vivo, Antonio; Spitaleri, Antonio; Gugliotta, Gabriele; Fabbiano, Francesco; Capodanno, Isabella; Mannina, Donato; Salvucci, Marzia; Antolino, Agostino; Marasca, Roberto; Musso, Maurizio; Crugnola, Monica; Impera, Stefana; Trabacchi, Elena; Musolino... Journal: American journal of hematology Issue: Volume 92:Issue 1(2017:Jan.) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis. (August 2012) Authors: Soverini, Simona; Martinelli, Giovanni; Rosti, Gianantonio; Iacobucci, Ilaria; Baccarani, Michele Journal: Pharmacogenomics Issue: Volume 13:Number 11(2012) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients. Issue 8 (August 2013) Authors: Broccoli, Alessandro; Stanzani, Marta; Bandini, Giuseppe; Bonifazi, Francesca; Stefoni, Vittorio; Pellegrini, Cinzia; Derenzini, Enrico; Gandolfi, Letizia; Quirini, Federica; Argnani, Lisa; Tschon, Marta; Casadei, Beatrice; Baccarani, Michele; Zinzani, Pier Luigi Journal: Leukemia & lymphoma Issue: Volume 54:Issue 8(2013:Aug.) Page Start: 1791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study. Issue 4 (29th October 2012) Authors: Zinzani, Pier Luigi; Pellegrini, Cinzia; Merla, Emanuela; Ballerini, Filippo; Fabbri, Alberto; Guarini, Attilio; Pavone, Vincenzo; Quintini, Gerlando; Puccini, Benedetta; Vigliotti, Maria Luigia; Stefoni, Vittorio; Derenzini, Enrico; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Cas... Journal: Hematological oncology Issue: Volume 31:Issue 4(2013:Dec.) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Current treatment approaches in CML. (June 2019) Authors: Castagnetti, Fausto; Gugliotta, Gabriele; Soverini, Simona; Baccarani, Michele; Rosti, Gianantonio Journal: HemaSphere Issue: Volume 3:Supplement 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia. Issue 3 (June 2014) Authors: Baccarani, Michele; Castagnetti, Fausto; Gugliotta, Gabriele; Palandri, Francesca; Rosti, Gianantonio Journal: Expert review of hematology Issue: Volume 7:Issue 3(2014) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement. Issue 7 (30th December 2013) Authors: Soverini, Simona; De Benedittis, Caterina; Papayannidis, Cristina; Paolini, Stefania; Venturi, Claudia; Iacobucci, Ilaria; Luppi, Mario; Bresciani, Paola; Salvucci, Marzia; Russo, Domenico; Sica, Simona; Orlandi, Ester; Intermesoli, Tamara; Gozzini, Antonella; Bonifacio, Massimiliano; Rigolin, Gi... Journal: Cancer Issue: Volume 120:Issue 7(2014) Page Start: 1002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement. Issue 7 (30th December 2013) Authors: Soverini, Simona; De Benedittis, Caterina; Papayannidis, Cristina; Paolini, Stefania; Venturi, Claudia; Iacobucci, Ilaria; Luppi, Mario; Bresciani, Paola; Salvucci, Marzia; Russo, Domenico; Sica, Simona; Orlandi, Ester; Intermesoli, Tamara; Gozzini, Antonella; Bonifacio, Massimiliano; Rigolin, Gi... Journal: Cancer Issue: Volume 120:Issue 7(2014) Page Start: 1002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Extranodal marginal zone B‐cell lymphoma of the lung: experience with fludarabine and mitoxantrone‐containing regimens. Issue 4 (5th December 2012) Authors: Zinzani, Pier Luigi; Pellegrini, Cinzia; Gandolfi, Letizia; Casadei, Beatrice; Derenzini, Enrico; Broccoli, Alessandro; Quirini, Federica; Argnani, Lisa; Pileri, Stefano; Celli, Monica; Fanti, Stefano; Poletti, Venerino; Stefoni, Vittorio; Baccarani, Michele Journal: Hematological oncology Issue: Volume 31:Issue 4(2013:Dec.) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic‐ or accelerated‐phase chronic myeloid leukemia: Results with 24 months of follow‐up. Issue 10 (13th January 2015) Authors: Cortes, Jorge E.; Kantarjian, Hagop M.; Rea, Delphine; Wetzler, Meir; Lipton, Jeffrey H.; Akard, Luke; Khoury, H. Jean; Michallet, Mauricette; Guerci‐Bresler, Agnès; Chuah, Charles; Hellmann, Andrzej; Digumarti, Raghunadharao; Parikh, Purvish M.; Legros, Laurence; Warzocha, Krzysztof; Baccarani, ... Journal: Cancer Issue: Volume 121:Issue 10(2015) Page Start: 1637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗